HomeCompareSCLTF vs MRK

SCLTF vs MRK: Dividend Comparison 2026

SCLTF yields 3210.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCLTF wins by $868001036828.71M in total portfolio value
10 years
SCLTF
SCLTF
● Live price
3210.27%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$868001036828.77M
Annual income
$817,883,765,700,886,400.00
Full SCLTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SCLTF vs MRK

📍 SCLTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCLTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCLTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCLTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCLTF
Annual income on $10K today (after 15% tax)
$272,873.19/yr
After 10yr DRIP, annual income (after tax)
$695,201,200,845,753,500.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SCLTF beats the other by $695,201,200,845,745,200.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCLTF + MRK for your $10,000?

SCLTF: 50%MRK: 50%
100% MRK50/50100% SCLTF
Portfolio after 10yr
$434000518414.41M
Annual income
$408,941,882,850,448,100.00/yr
Blended yield
94.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCLTF
No analyst data
Altman Z
-31.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCLTF buys
0
MRK buys
0
No recent congressional trades found for SCLTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCLTFMRK
Forward yield3210.27%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$868001036828.77M$56.8K
Annual income after 10y$817,883,765,700,886,400.00$9,798.13
Total dividends collected$864548114577.74M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCLTF vs MRK ($10,000, DRIP)

YearSCLTF PortfolioSCLTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$331,727$321,027.29$11,206$366.19+$320.5KSCLTF
2$10,307,613$9,952,664.60$12,650$502.35+$10.29MSCLTF
3$300,052,202$289,023,056.50$14,407$694.19+$300.04MSCLTF
4$8,184,040,627$7,862,984,770.50$16,585$967.82+$8184.02MSCLTF
5$209,192,410,129$200,435,486,658.76$19,342$1,363.89+$209192.39MSCLTF
6$5,011,999,515,282$4,788,163,636,443.06$22,913$1,947.19+$5011999.49MSCLTF
7$112,576,544,225,493$107,213,704,744,142.06$27,662$2,823.89+$112576544.20MSCLTF
8$2,371,083,350,433,164$2,250,626,448,111,885.50$34,159$4,173.35+$2371083350.40MSCLTF
9$46,838,571,147,553,416$44,301,511,962,589,930.00$43,337$6,308.80+$46838571147.51MSCLTF
10$868,001,036,828,768,500$817,883,765,700,886,400.00$56,776$9,798.13+$868001036828.71MSCLTF

SCLTF vs MRK: Complete Analysis 2026

SCLTFStock

Searchlight Resources Inc., an exploration stage company, acquires, explores for, and develops mineral properties in Canada. It explores for copper, lead, cobalt, gold, vanadium, nickel, and uranium deposits, as well as rare earth elements. The company holds interests in the Kulyk Lake rare earth project located to the north La Ronge, Saskatchewan; the Bootleg Lake gold property located near Creighton, Saskatchewan; and the Duddridge Lake property located to the northwest of La Ronge, Saskatchewan. It also holds interests in the Flin Flon North project located in Saskatchewan; the Reef Lake nickel project located in north central Saskatchewan; and the Wapawekka Greenstone project located to western section of Wapawekka Greenstone Belt. In addition, it has an option to acquire a 100% interest in the Robinson Creek gold project located to the west of Creighton, Saskatchewan. The company was formerly known as Canyon Copper Corp. and changed its name to Searchlight Resources Inc. in July 2018. Searchlight Resources Inc. was incorporated in 2000 and is headquartered in Vancouver, Canada.

Full SCLTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SCLTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCLTF vs SCHDSCLTF vs JEPISCLTF vs OSCLTF vs KOSCLTF vs MAINSCLTF vs JNJSCLTF vs ABBVSCLTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.